Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AMS NASDAQ:BDSX NASDAQ:BMGL NASDAQ:PIII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$2.62+1.2%$2.49$2.27▼$4.60$17.06M0.314,457 shs4,938 shsBDSXBiodesix$0.40-0.2%$0.33$0.17▼$2.04$58.11M0.991.55 million shs495,700 shsBMGLBasel Medical Group$1.97-3.9%$2.44$0.91▼$9.40$36.35MN/A197,998 shs91,715 shsPIIIP3 Health Partners$6.78-2.3%$6.59$5.80▼$30.49$48.75M0.8111,974 shs9,173 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services0.00%+3.15%+3.56%+4.80%-2.24%BDSXBiodesix0.00%-1.05%+24.12%+31.66%-77.22%BMGLBasel Medical Group0.00%-5.29%-17.92%-7.51%+196,999,900.00%PIIIP3 Health Partners0.00%+3.78%+2.57%-14.61%-77.35%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSAmerican Shared Hospital Services1.2091 of 5 stars0.03.00.00.03.31.70.6BDSXBiodesix3.1521 of 5 stars3.45.00.00.01.52.50.6BMGLBasel Medical GroupN/AN/AN/AN/AN/AN/AN/AN/APIIIP3 Health Partners2.0794 of 5 stars3.32.00.00.01.50.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital Services 0.00N/AN/AN/ABDSXBiodesix 2.80Moderate Buy$1.75341.58% UpsideBMGLBasel Medical Group 0.00N/AN/AN/APIIIP3 Health Partners 2.50Moderate Buy$16.25139.68% UpsideCurrent Analyst Ratings BreakdownLatest AMS, BDSX, PIII, and BMGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025BDSXBiodesixScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$3.00 ➝ $2.00(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$28.34M0.60$0.89 per share2.95$4.68 per share0.56BDSXBiodesix$71.32M0.81N/AN/A$0.14 per share2.83BMGLBasel Medical GroupN/AN/AN/AN/AN/AN/APIIIP3 Health Partners$1.50B0.03N/AN/A$10.58 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services$2.19M$0.60N/A8.73N/A-8.27%-8.07%-3.87%N/ABDSXBiodesix-$42.93M-$0.29N/AN/AN/A-53.66%-269.67%-43.94%N/ABMGLBasel Medical GroupN/AN/A0.00∞N/AN/AN/AN/AN/APIIIP3 Health Partners-$135.85M-$46.01N/AN/AN/A-9.99%-161.27%-17.45%N/ALatest AMS, BDSX, PIII, and BMGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025PIIIP3 Health Partners-$3.29-$6.23-$2.94-$6.23$356.52 million$355.79 million8/7/2025Q2 2025BDSXBiodesix-$0.07-$0.08-$0.01-$0.08$18.47 million$20.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/ABDSXBiodesixN/AN/AN/AN/AN/ABMGLBasel Medical GroupN/AN/AN/AN/AN/APIIIP3 Health PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital Services0.321.171.17BDSXBiodesix41.112.142.14BMGLBasel Medical GroupN/AN/AN/APIIIP3 Health Partners1.680.380.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%BDSXBiodesix20.96%BMGLBasel Medical GroupN/APIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services23.80%BDSXBiodesix30.10%BMGLBasel Medical GroupN/APIIIP3 Health Partners17.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services106.51 million4.96 millionNot OptionableBDSXBiodesix220146.63 million102.50 millionOptionableBMGLBasel Medical Group3618.45 millionN/AN/APIIIP3 Health Partners5007.19 million5.91 millionNot OptionableAMS, BDSX, PIII, and BMGL HeadlinesRecent News About These CompaniesP3 Health Partners Inc. (PIII) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comP3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue EstimatesAugust 14, 2025 | zacks.comP3 Health Partners Announces Second Quarter 2025 ResultsAugust 14, 2025 | businesswire.comP3 Health Partners (PIII) Expected to Announce Earnings on ThursdayAugust 13, 2025 | americanbankingnews.comP3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference CallJuly 31, 2025 | businesswire.comP3 Health Partners (PIII) Projected to Post Quarterly Earnings on WednesdayJuly 30, 2025 | marketbeat.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 28, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 22, 2025 | globenewswire.comP3 Health Partners Inc. (PIII) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 16, 2025 | globenewswire.comBears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' NowJune 12, 2025 | zacks.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 6, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 3, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.May 27, 2025 | globenewswire.comDown 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)May 26, 2025 | zacks.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.May 23, 2025 | globenewswire.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comP3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look ForMay 16, 2025 | finance.yahoo.comP3 Health Partners Inc (PIII) Q1 2025 Earnings Call Highlights: Strategic Adjustments and ...May 16, 2025 | finance.yahoo.comP3 Health Partners reaffirms $130M EBITDA improvement plan as operational initiatives accelerate in 2025May 16, 2025 | msn.comP3 Health Partners Inc. (PIII) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Tesla Teams With Samsung—Will Other Chipmakers Follow?By Gabriel Osorio-Mazilli | August 1, 20253 Natural Gas Stocks Powering the AI Data Center BoomBy Chris Markoch | August 11, 2025Newmont's Financial Strength Sets a High Bar for Gold MinersBy Jeffrey Neal Johnson | August 1, 2025Baidu Teams With Uber and Lyft on Robotaxis—Stock Upside Ahead?By Gabriel Osorio-Mazilli | August 15, 2025AMS, BDSX, PIII, and BMGL Company DescriptionsAmerican Shared Hospital Services NYSEAMERICAN:AMS$2.62 +0.03 (+1.16%) Closing price 08/15/2025 04:10 PM EasternExtended Trading$2.64 +0.01 (+0.57%) As of 08/15/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Biodesix NASDAQ:BDSX$0.40 0.00 (-0.18%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$0.39 -0.01 (-2.60%) As of 08/15/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.Basel Medical Group NASDAQ:BMGL$1.97 -0.08 (-3.90%) As of 08/15/2025 04:00 PM EasternBasel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.P3 Health Partners NASDAQ:PIII$6.78 -0.16 (-2.31%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$6.79 +0.01 (+0.15%) As of 08/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Is Reddit Stock Too Hot, or Just Right? Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access